Fu Wanting, Cui Qiuying, Yang Ziyao, Bu Zhiqin, Shi Hao, Bi Beibei, Yang Qingling, Xin Hang, Shi Senlin, Hu Linli
Centre for Reproductive Medicine, The First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, China; Henan Key Laboratory of Reproduction and Genetics, The First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, China; Henan Provincial Obstetrical and Gynaecological Diseases (Reproductive Medicine) Clinical Research Centre, The First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, China; Henan Engineering Laboratory of Preimplantation Genetic Diagnosis and Screening, The First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, China.
Centre for Reproductive Medicine, The First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, China; Henan Key Laboratory of Reproduction and Genetics, The First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, China; Henan Provincial Obstetrical and Gynaecological Diseases (Reproductive Medicine) Clinical Research Centre, The First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, China; Henan Engineering Laboratory of Preimplantation Genetic Diagnosis and Screening, The First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, China.
Reprod Biomed Online. 2023 Dec;47(6):103366. doi: 10.1016/j.rbmo.2023.103366. Epub 2023 Aug 22.
Is high sperm DNA fragmentation (SDF) associated with a high embryonic aneuploidy rate in patients undergoing intracytoplasmic sperm injection (ICSI)-preimplantation genetic testing (PGT)?
This was a retrospective study of 426 couples with normal karyotypes undergoing ICSI-PGT at the authors' centre from March 2017 to March 2021. SDF was assessed using the sperm chromatin structure assay. The population was divided into low and high SDF groups according to cut-off values found by the receiver operating characteristic (ROC) curve. A 1:1 ratio propensity score matching (PSM) method was used to control for potential confounding factors, and a generalized linear mixed model was established to evaluate the relationship between SDF and the embryonic aneuploidy rate.
The ROC curve indicated a threshold of 30%. In total, 132 couples were included after PSM, and the high SDF group (>30%) had significantly higher SDF (40.74% ± 9.78% versus 15.54% ± 7.86%, P < 0.001) and a higher embryo aneuploidy rate (69.36% versus 53.96%, P < 0.001) compared with the low SDF group (≤30%). The two pronuclear fertilization rate, cleavage rate, rate of high-quality embryos at day 3 rate, blastocyst rate, biochemical pregnancy rate, clinical pregnancy rate, miscarriage rate, live birth rate, caesarean section rate, preterm birth rate, singleton rate and low birthweight rate were similar in both groups (P > 0.05). After PSM, SDF > 30% was significantly correlated with an increased embryo aneuploidy rate after adjusting for all confounding variables (adjusted odds ratio 1.70, 95% CI 1.00-2.88, P = 0.049).
SDF > 30% was associated with an increased embryo aneuploidy rate in couples with normal karyotypes undergoing PGT, but did not affect embryonic and clinical outcomes after transfer of euploid embryos.
在接受卵胞浆内单精子注射(ICSI)-植入前基因检测(PGT)的患者中,高精子DNA碎片率(SDF)是否与高胚胎非整倍体率相关?
这是一项对2017年3月至2021年3月在作者所在中心接受ICSI-PGT且核型正常的426对夫妇进行的回顾性研究。使用精子染色质结构分析评估SDF。根据受试者工作特征(ROC)曲线确定的临界值,将研究人群分为低SDF组和高SDF组。采用1:1比例的倾向评分匹配(PSM)方法控制潜在混杂因素,并建立广义线性混合模型评估SDF与胚胎非整倍体率之间的关系。
ROC曲线显示临界值为30%。PSM后共纳入132对夫妇,高SDF组(>30%)的SDF显著高于低SDF组(≤30%)(40.74%±9.78%对15.54%±7.86%,P<0.001),胚胎非整倍体率也更高(69.36%对53.96%,P<0.001)。两组的双原核受精率、卵裂率、第3天优质胚胎率、囊胚率、生化妊娠率、临床妊娠率、流产率、活产率、剖宫产率、早产率、单胎率和低出生体重率相似(P>0.05)。PSM后,在调整所有混杂变量后,SDF>30%与胚胎非整倍体率增加显著相关(调整后的优势比为1.70,95%CI为1.00-2.88,P=0.049)。
在接受PGT且核型正常的夫妇中,SDF>30%与胚胎非整倍体率增加相关,但不影响整倍体胚胎移植后的胚胎及临床结局。